These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21411816)

  • 1. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1.
    Cudmore MJ; Ahmad S; Sissaoui S; Ramma W; Ma B; Fujisawa T; Al-Ani B; Wang K; Cai M; Crispi F; Hewett PW; Gratacós E; Egginton S; Ahmed A
    Eur Heart J; 2012 May; 33(9):1150-8. PubMed ID: 21411816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
    Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
    Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.
    Aoki Y; Yamamoto T; Fumihisa C; Nakamura A; Asanuma A; Suzuki M
    Am J Reprod Immunol; 2012 May; 67(5):413-20. PubMed ID: 22040284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.
    Ke B; Shen XD; Ji H; Kamo N; Gao F; Freitas MC; Busuttil RW; Kupiec-Weglinski JW
    J Hepatol; 2012 Feb; 56(2):359-66. PubMed ID: 21756853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.
    Ahmed A
    Thromb Res; 2011 Feb; 127 Suppl 3():S72-5. PubMed ID: 21262447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms and therapeutic implications of the carbon monoxide/hmox1 and the hydrogen sulfide/CSE pathways in the prevention of pre-eclampsia and fetal growth restriction.
    Ahmed A
    Pregnancy Hypertens; 2014 Jul; 4(3):243-4. PubMed ID: 26104642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble endoglin contributes to the pathogenesis of preeclampsia.
    Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
    Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.
    Zhou CC; Irani RA; Zhang Y; Blackwell SC; Mi T; Wen J; Shelat H; Geng YJ; Ramin SM; Kellems RE; Xia Y
    Circulation; 2010 Jan; 121(3):436-44. PubMed ID: 20065159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling.
    Findley CM; Cudmore MJ; Ahmed A; Kontos CD
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2619-26. PubMed ID: 17901375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?
    Ahmed A; Cudmore MJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1237-42. PubMed ID: 19909254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells.
    Romani F; Lanzone A; Tropea A; Tiberi F; Catino S; Apa R
    Placenta; 2011 Feb; 32(2):153-60. PubMed ID: 21145589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: the enigmatic role of endoglin in the placenta.
    Gregory AL; Xu G; Sotov V; Letarte M
    Placenta; 2014 Feb; 35 Suppl():S93-9. PubMed ID: 24252708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2.
    Sako K; Fukuhara S; Minami T; Hamakubo T; Song H; Kodama T; Fukamizu A; Gutkind JS; Koh GY; Mochizuki N
    J Biol Chem; 2009 Feb; 284(9):5592-601. PubMed ID: 19106103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.